{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T20:41:43Z","timestamp":1785789703869,"version":"3.56.0"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1016\/j.yebeh.2003.11.026","type":"journal-article","created":{"date-parts":[[2004,1,23]],"date-time":"2004-01-23T10:18:16Z","timestamp":1074853096000},"page":"3-15","source":"Crossref","is-referenced-by-count":124,"special_numbering":"S2","title":["Pathophysiology of bone loss in patients receiving anticonvulsant therapy"],"prefix":"10.1016","volume":"5","author":[{"given":"Lorraine A.","family":"Fitzpatrick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2003.11.026_BIB1","series-title":"Primer on the metabolic bone diseases and disorders of mineral metabolism","first-page":"74","article-title":"Mineral balance and homeostasis","author":"Broadus","year":"1999"},{"key":"10.1016\/j.yebeh.2003.11.026_BIB2","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1210\/endo-62-6-717","article-title":"Removal of calcium from bone as influenced by the parathyroids","volume":"62","author":"Talmage","year":"1958","journal-title":"Endocrinology"},{"key":"10.1016\/j.yebeh.2003.11.026_BIB3","first-page":"209","article-title":"Osteoclast ontogeny and function","volume":"vol. 5","author":"Mundy","year":"1987"},{"key":"10.1016\/j.yebeh.2003.11.026_BIB4","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1146\/annurev.ph.43.030181.003033","article-title":"Distribution of hormone-dependent adenylate cyclase in the nephron and its physiological significance","volume":"43","author":"Morel","year":"1981","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB5","series-title":"Endocrinology","first-page":"990","article-title":"Vitamin D: photobiology, metabolism, and clinical applications","author":"Holick","year":"1995"},{"key":"10.1016\/j.yebeh.2003.11.026_BIB6","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/ajcn\/60.4.619","article-title":"Vitamin D: new horizons for the 21st century","volume":"60","author":"Holick","year":"1994","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB7","first-page":"F157","article-title":"Vitamin D","volume":"277","author":"Brown","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB8","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1056\/NEJM199204303261802","article-title":"The vitamin D content of fortified milk and infant formula","volume":"326","author":"Holick","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB9","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1096\/fasebj.2.3.3280376","article-title":"The vitamin D story: a collaborative effort of basic science and clinical medicine","volume":"2","author":"DeLuca","year":"1988","journal-title":"FASEB J."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB10","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJM198904133201506","article-title":"The role of the vitamin D endocrine system in health and disease","volume":"320","author":"Reichel","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB11","first-page":"S260","article-title":"Direct regulation of 25-hydroxyvitamin D3 1\u03b1-hydroxylase by calcium in a human proximal tubule cell line (abstract)","volume":"23","author":"Bland","year":"1998","journal-title":"Bone"},{"key":"10.1016\/j.yebeh.2003.11.026_BIB12","series-title":"Women's sport medicine and rehabilitation","first-page":"259","article-title":"Bone metabolism\u2014bone loss and injury in the female athlete","author":"Fitzpatrick","year":"2001"},{"key":"10.1016\/j.yebeh.2003.11.026_BIB13","first-page":"99","article-title":"The two-stage concept of bone loss revisited","volume":"31","author":"Parfitt","year":"1992","journal-title":"Triangle"},{"key":"10.1016\/j.yebeh.2003.11.026_BIB14","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/jcb.240550303","article-title":"Osteonal and hemi-osteonal remodeling: the spatial and temporal framework for signal traffic in adult human bone","volume":"55","author":"Parfitt","year":"1994","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB15","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/1047-2797(94)00100-8","article-title":"Lifetime occupational physical activity and risk of hip fracture in women","volume":"5","author":"Jaglal","year":"1995","journal-title":"Ann. Epidemiol."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1600-0404.1999.tb00675.x","article-title":"Fracture risk is increased in epilepsy","volume":"99","author":"Vestergaard","year":"1999","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1136\/bmj.4.5727.69","article-title":"Osteomalacia with long-term anticonvulsant therapy in epilepsy","volume":"4","author":"Dent","year":"1970","journal-title":"Br. Med. J."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/bmj.4.5727.73","article-title":"Disturbance of calcium metabolism by anticonvulsant drugs","volume":"4","author":"Richens","year":"1970","journal-title":"Br. Med. J."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB19","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1136\/bmj.4.5781.202","article-title":"Altered calcium metabolism in epileptic children on anticonvulsants","volume":"4","author":"Hunter","year":"1971","journal-title":"Br. Med. J."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1542\/peds.56.1.45","article-title":"Osteomalacia associated with anticonvulsant drug therapy in mentally retarded children","volume":"56","author":"Tolman","year":"1975","journal-title":"Pediatrics"},{"key":"10.1016\/j.yebeh.2003.11.026_BIB21","first-page":"715","article-title":"Bone disease induced by anticonvulsant therapy and treatment with calcitriol (1,25-dihydroxy-vitamin D3)","volume":"140","author":"Hunt","year":"1986","journal-title":"Am. J. Dis. Child"},{"key":"10.1016\/j.yebeh.2003.11.026_BIB22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1528-1157.1979.tb04771.x","article-title":"Antiepileptic drugs and vitamin D supplementation","volume":"20","author":"Offermann","year":"1979","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2003.11.026_BIB23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0020-1383(95)00189-1","article-title":"Incidence of five common fracture types in an institutional epileptic population","volume":"27","author":"Desai","year":"1996","journal-title":"Injury"},{"key":"10.1016\/j.yebeh.2003.11.026_BIB24","series-title":"Antiepileptic therapy: chronic toxicity of antiepileptic drugs","first-page":"185","article-title":"Effect of antiepileptic drug therapy and exposure to sunlight on vitamin D status in institutionalized patients","author":"Berry","year":"1983"},{"key":"10.1016\/j.yebeh.2003.11.026_BIB25","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1001\/jama.224.12.1634","article-title":"Anticonvulsant drugs and vitamin D metabolism","volume":"224","author":"Livingston","year":"1973","journal-title":"JAMA"},{"key":"10.1016\/j.yebeh.2003.11.026_BIB26","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1177\/003693308202700205","article-title":"Do anticonvulsant drugs commonly induce osteomalacia?","volume":"27","author":"Fogelman","year":"1982","journal-title":"Scott. Med. J."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB27","first-page":"635","article-title":"Calcium metabolism in adult outpatients with epilepsy receiving long-term anticonvulsant therapy","volume":"118","author":"Pylypchuk","year":"1978","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB28","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/BF00442080","article-title":"Calcium metabolism and vitamin D metabolite levels in children receiving anticonvulsant drugs","volume":"139","author":"Keck","year":"1982","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1528-1157.1977.tb05585.x","article-title":"Evidence of osteomalacia in an outpatient group of adult epileptics","volume":"18","author":"Ashworth","year":"1977","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2003.11.026_BIB30","first-page":"129","article-title":"Anticonvulsant osteomalacia in epileptic outpatients","volume":"14","author":"Hoikka","year":"1982","journal-title":"Ann. Clin. Res."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB31","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1600-0404.1986.tb03515.x","article-title":"Anticonvulsant drugs and bone metabolism","volume":"74","author":"Bogliun","year":"1986","journal-title":"Acta. Neurol. Scand."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB32","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1210\/jcem-58-6-1003","article-title":"Decreased serum ionized calcium and normal vitamin D metabolite levels with anticonvulsant drug treatment","volume":"58","author":"Weinstein","year":"1984","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB33","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1056\/NEJM197211022871803","article-title":"Effect of chronic anticonvulsant therapy on serum 25-hydroxycalciferol levels in adults","volume":"287","author":"Hahn","year":"1972","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB34","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1056\/NEJM197503132921102","article-title":"Serum 25-hydroxycalciferol levels and bone mass in children on chronic anticonvulsant therapy","volume":"292","author":"Hahn","year":"1975","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB35","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/BF02546458","article-title":"Treatment of anticonvulsant osteomalacia with vitamin D","volume":"21","author":"Christiansen","year":"1976","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB36","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF02939839","article-title":"Factors associated with the biochemical changes in vitamin D and calcium metabolism in institutionalized patients with epilepsy","volume":"155","author":"Gough","year":"1986","journal-title":"Ir. J. Med. Sci."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB37","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1056\/NEJM199503233321202","article-title":"Risk factors for hip fracture in white women: Study of Osteoporotic Fractures Research Group","volume":"332","author":"Cummings","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB38","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/archneur.59.5.781","article-title":"Antiepileptic drug-induced bone loss in young male patients who have seizures","volume":"59","author":"Andress","year":"2002","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB39","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/cpt197619163","article-title":"Calcium balance in drug-induced osteomalacia: response to vitamin D","volume":"19","author":"Peterson","year":"1976","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB40","first-page":"113","article-title":"A prospective study to evaluate the dose of vitamin D required to correct low 25-hydroxyvitamin D levels, calcium, and alkaline phosphatase in patients at risk of developing antiepileptic drug-induced osteomalacia","volume":"78","author":"Collins","year":"1991","journal-title":"Q. J. Med."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB41","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev.nutr.22.120501.150216","article-title":"Hydroxylase enzymes of the vitamin D pathway: expression, function, and regulation","volume":"22","author":"Omdahl","year":"2002","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB42","first-page":"569","article-title":"A comparative study of the relative influence of different anticonvulsant drugs, UV exposure and diet on vitamin D and calcium metabolism in out-patients with epilepsy","volume":"59","author":"Gough","year":"1986","journal-title":"Q. J. Med."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB43","first-page":"79","article-title":"Low plasma 25-hydroxyvitamin D and serum calcium levels in institutionalized epileptic subjects: associated risk factors, consequences and response to treatment with vitamin D","volume":"52","author":"Davie","year":"1983","journal-title":"Q. J. Med."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB44","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/j.1552-4604.1976.tb02417.x","article-title":"Absorption and biotransformation of cholecalciferol in drug-induced osteomalacia","volume":"16","author":"Matheson","year":"1976","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB45","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1172\/JCI106868","article-title":"Phenobarbital-induced alterations in vitamin D metabolism","volume":"51","author":"Hahn","year":"1972","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB46","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1210\/en.142.7.3135","article-title":"Targeted inactivation of the 25-hydroxyvitamin D3-1(alpha)-hydroxylase gene (CYP27-B1) creates an animal model of pseudovitamin D-deficiency rickets","volume":"142","author":"Dardenne","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.yebeh.2003.11.026_BIB47","doi-asserted-by":"crossref","first-page":"7498","DOI":"10.1073\/pnas.131029498","article-title":"Targeted ablation of the 25-hydroxyvitamin D 1 alpha-hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction","volume":"98","author":"Panda","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.yebeh.2003.11.026_BIB48","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0014-5793(91)80115-J","article-title":"Cloning and expression of cDNA encoding 25-hydroxyvitamin D3 24-hydroxylase","volume":"278","author":"Ohyama","year":"1991","journal-title":"FEBS Lett."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB49","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1359\/jbmr.1997.12.10.1552","article-title":"The 25-hydroxyvitamin D 1-alpha-hydroxylase gene maps to the pseudovitamin D\u2013deficiency rickets (PDDR) disease locus","volume":"12","author":"St. Arnaud","year":"1997","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB50","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1086\/302156","article-title":"Genetics of vitamin D 1alpha-hydroxylase deficiency in 17 families","volume":"63","author":"Wang","year":"1998","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB51","first-page":"378","article-title":"Osteopathien bei antiepileptischer Langzeittherapie (vorl\u00e4ufige Mitteilung)","volume":"116","author":"Kruse","year":"1968","journal-title":"Monatsschr. Kinderheilkd."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB52","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1136\/bmj.3.5771.433-a","article-title":"Bone density and long-term anticonvulsant therapy","volume":"3","author":"Linde","year":"1971","journal-title":"Br. Med. J."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB53","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1600-0404.1971.tb07517.x","article-title":"Bone density in patients receiving long-term anticonvulsant therapy","volume":"47","author":"Linde","year":"1971","journal-title":"Acta. Neurol. Scand."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB54","doi-asserted-by":"crossref","first-page":"453","DOI":"10.4065\/77.5.453","article-title":"Secondary causes of osteoporosis","volume":"77","author":"Fitzpatrick","year":"2002","journal-title":"Mayo. Clin. Proc."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB55","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/bmj.4.5831.9","article-title":"Plasma levels and therapeutic effect of 25-hydroxycholecalciferol in epileptic patients taking anticonvulsant drugs","volume":"4","author":"Stamp","year":"1972","journal-title":"Br. Med. J."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB56","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0022-3476(73)80223-9","article-title":"Vitamin D-dependent rickets in institutionalized, mentally retarded children receiving long-term anticonvulsant therapy. I. A survey of 288 patients","volume":"83","author":"Lifshitz","year":"1973","journal-title":"J. Pediatr."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB57","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1212\/WNL.58.9.1348","article-title":"Effect of antiepileptic drugs on bone density in ambulatory patients","volume":"58","author":"Farhat","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2003.11.026_BIB58","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0002-9343(02)01091-4","article-title":"Vitamin D insufficiency among free-living healthy young adults","volume":"112","author":"Tangpricha","year":"2002","journal-title":"Am. J. Med."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB59","unstructured":"Holick M. Vitamin D: importance for bone and cardiovascular health and for cancer and diabetes prevention. Paper presented at: Endo 2003, 85th Annual Meeting of the Endocrine Society, Philadelphia, June 21, 2003. Abstract N3-1"},{"key":"10.1016\/j.yebeh.2003.11.026_BIB60","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/jbmr.5650090507","article-title":"Bone mineral density measured by dual-energy X-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs","volume":"9","author":"V\u00e4lim\u00e4ki","year":"1994","journal-title":"J. Bone Miner. Res."},{"issue":"Suppl. 7","key":"10.1016\/j.yebeh.2003.11.026_BIB61","first-page":"292","article-title":"Possible mechanisms of bone disease in women receiving antiepileptic drug (AED) monotherapy (abstract)","volume":"42","author":"Pack","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2003.11.026_BIB62","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF00610388","article-title":"Hepatic enzyme induction and vitamin K1 elimination in man","volume":"33","author":"Scott","year":"1987","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB63","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/8756-3282(90)90085-D","article-title":"Phenytoin affects osteocalcin secretion from osteoblastic rat osteosarcoma 17\/2.8 cells in culture","volume":"11","author":"Vernillo","year":"1990","journal-title":"Bone"},{"key":"10.1016\/j.yebeh.2003.11.026_BIB64","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/135652b0","article-title":"The antihemorrhagic vitamin of the chick: occurrence and chemical nature","volume":"135","author":"Dam","year":"1935","journal-title":"Nature"},{"key":"10.1016\/j.yebeh.2003.11.026_BIB65","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/00075197-200111000-00003","article-title":"Effects of vitamin K on calcium and bone metabolism","volume":"4","author":"Zittermann","year":"2001","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB66","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/382448a0","article-title":"Increased bone formation in osteocalcin-deficient mice","volume":"382","author":"Ducy","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.yebeh.2003.11.026_BIB67","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/5102","article-title":"Mutations in the gene encoding the human matrix Gla protein cause Keutel syndrome","volume":"21","author":"Munroe","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB68","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/S0024-3205(01)01522-3","article-title":"Effects of phenytoin and\/or vitamin K2 (menatetrenone) on bone mineral density in the tibiae of growing rats","volume":"70","author":"Onodera","year":"2002","journal-title":"Life Sci."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB69","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1210\/endo-92-1-330","article-title":"Diphenylhydantoin inhibition of calcitonin secretion in the pig","volume":"92","author":"Pento","year":"1973","journal-title":"Endocrinology"},{"key":"10.1016\/j.yebeh.2003.11.026_BIB70","first-page":"38","article-title":"Inhibition of calcitonin secretion\/synthesis by anticonvulsant drugs","volume":"96","author":"Kruse","year":"1981","journal-title":"Acta Endocrinol."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB71","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1046\/j.1528-1157.2002.13002.x","article-title":"Increased bone turnover in prepubertal, pubertal, and postpubertal patients receiving carbamazepine","volume":"43","author":"Verrotti","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2003.11.026_BIB72","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/jbmr.5650080202","article-title":"Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry","volume":"8","author":"Eriksen","year":"1993","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB73","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1515\/CCLM.2000.008","article-title":"Changes in bone turnover and deoxypyridinoline levels in epileptic patients","volume":"38","author":"Telci","year":"2000","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB74","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1212\/WNL.57.3.445","article-title":"Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy","volume":"57","author":"Sato","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2003.11.026_BIB75","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1525-5050(03)00036-2","article-title":"Bone mineral density in an outpatient population receiving enzyme-inducing antiepileptic drugs","volume":"4","author":"Pack","year":"2003","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB76","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1053\/seiz.1999.0301","article-title":"Bone density and antiepileptic drugs: a case-controlled study","volume":"8","author":"Stephen","year":"1999","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2003.11.026_BIB77","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/00220345950740010801","article-title":"Phenytoin at micromolar concentrations is an osteogenic agent for human-mandible-derived bone cells in vitro","volume":"74","author":"Nakade","year":"1995","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB78","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1254\/jjp.82.82","article-title":"Phenytoin and its metabolite, 5-(4-hydroxyphenyl)-5-phenylhydantoin, show bone resorption in cultured neonatal mouse calvaria","volume":"82","author":"Takahashi","year":"2000","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB79","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1172\/JCI109142","article-title":"Interaction of diphenylhydantoin (phenytoin) and phenobarbital with hormonal mediation of fetal rat bone resorption in vitro","volume":"62","author":"Hahn","year":"1978","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB80","first-page":"37","article-title":"Long-term anticonvulsant therapy leads to low bone mineral density: evidence for direct drug effects of phenytoin and carbamazepine on human osteoblast-like cells","volume":"108","author":"Feldkamp","year":"2000","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.yebeh.2003.11.026_BIB81","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0024-3205(90)90014-I","article-title":"The effect of phenytoin on parathyroid hormone stimulated cAMP activity in cultured murine osteoblasts","volume":"46","author":"Auszmann","year":"1990","journal-title":"Life Sci."},{"key":"10.1016\/j.yebeh.2003.11.026_BIB82","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1002\/jbmr.5650111208","article-title":"Osteogenic actions of phenytoin in human bone cells are mediated in part by TGF-beta 1","volume":"11","author":"Nakade","year":"1996","journal-title":"J. Bone Miner. Res."}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505003003846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505003003846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T19:36:55Z","timestamp":1682624215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505003003846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":82,"alternative-id":["S1525505003003846"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2003.11.026","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}